Latest Articles
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer - allsci.com
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer allsci.com
Published: Aug. 18, 2026, 2:27 p.m.
Short-term weight loss before surgery may cut complications in endometrial cancer - Daijiworld
Short-term weight loss before surgery may cut complications in endometrial cancer Daijiworld
Published: Aug. 18, 2026, 3:44 a.m.
FDA grants fast track status to Faeth’s endometrial cancer drug By Investing.com - Investing.com South Africa
FDA grants fast track status to Faeth’s endometrial cancer drug By Investing.com Investing.com South Africa
Published: Aug. 17, 2026, 10:34 p.m.
Exclusive BAC Article: Faeth Therapeutics; Year-End 2026 PIKTOR Endometrial Cancer Data, Breast Cancer Interim Results 2027, Solid Tumor Expansions, And Catalysts (NASDAQ:FTH) - Seeking Alpha
Exclusive BAC Article: Faeth Therapeutics; Year-End 2026 PIKTOR Endometrial Cancer Data, Breast Cancer Interim Results 2027, Solid Tumor Expansions, And Catalysts (NASDAQ:FTH) Seeking Alpha
Published: Aug. 17, 2026, 7:11 p.m.
Weight Loss Cuts Endometrial Cancer Surgery Complications - EMJ
Weight Loss Cuts Endometrial Cancer Surgery Complications EMJ
Published: Aug. 17, 2026, 2:41 p.m.
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - BioSpace
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer BioSpace
Published: Aug. 17, 2026, 1:47 p.m.
FDA grants fast track status to Faeth’s endometrial cancer drug - Investing.com
FDA grants fast track status to Faeth’s endometrial cancer drug Investing.com
Published: Aug. 17, 2026, 12:57 p.m.
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Ca - GuruFocus
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Ca GuruFocus
Published: Aug. 17, 2026, 12:03 p.m.
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Cancer Combo Therapy - GuruFocus
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Cancer Combo Therapy GuruFocus
Published: Aug. 17, 2026, 12:03 p.m.
FDA grants fast track status to Faeth’s endometrial cancer drug By Investing.com - Investing.com Nigeria
FDA grants fast track status to Faeth’s endometrial cancer drug By Investing.com Investing.com Nigeria
Published: Aug. 17, 2026, 12:02 p.m.
Link copied to clipboard!